Last 37 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -53.03 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 7.47 | 6.78 | 9.57 | 7.02 | 8.35 | 5.64 | 6.14 | 7.27 | 7.49 | 7.50 | 7.19 | 9.51 | 5.35 | 8.29 | 9.05 | 8.98 | 9.14 | 8.75 | 8.05 | 10.65 | 11.53 |
| — | +20.1% | +55.9% | -3.4% | +11.5% | -24.8% | -14.6% | -23.6% | +40.1% | -9.5% | -20.6% | +5.9% | -41.5% | -5.2% | +12.4% | -15.7% | -20.7% | -41.1% | -50.7% | -13.2% | +39.9% | |
| P/B Ratio | 84.31 | 125.22 | 119.63 | 113.78 | 91.68 | 74.20 | 55.31 | 31.20 | 25.11 | 36.92 | 28.17 | 24.85 | 36.68 | 41.90 | 32.03 | — | — | 881.22 | 83.61 | 34.25 | 32.09 |
| — | +68.8% | +116.3% | +264.6% | +265.1% | +101.0% | +96.4% | +25.6% | -31.5% | -11.9% | -12.1% | — | — | -95.2% | -61.7% | — | — | +3045.8% | +175.1% | +66.8% | +170.7% | |
| P/FCF | — | 71.66 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.1% | 70.6% | 70.7% | 70.5% | 70.1% | 68.8% | 67.2% | 68.5% | 63.9% | 65.6% | 65.6% | 65.2% | 67.7% | 62.3% | 64.7% | 64.3% | 68.1% | 66.7% | 64.8% | 68.6% |
| — | -1.5% | +2.7% | +5.2% | +2.9% | +9.6% | +4.8% | +2.5% | +5.0% | -5.5% | +5.3% | +1.5% | +1.5% | -0.6% | -6.5% | -0.3% | -6.3% | +0.8% | -0.7% | -2.1% | +26.3% | |
| Operating Margin | -18.5% | -3.6% | -6.4% | -10.9% | -6.1% | -7.5% | -27.5% | -41.0% | -41.9% | -32.7% | -21.2% | -23.8% | -70.1% | -54.6% | -28.2% | -17.5% | -30.0% | -27.5% | -25.3% | -14.5% | -26.5% |
| — | +51.3% | +76.9% | +73.4% | +85.5% | +77.1% | -29.8% | -72.3% | +40.1% | +40.2% | +25.0% | -35.5% | -133.3% | -98.7% | -11.8% | -21.0% | -13.2% | +11.7% | -74.4% | -109.8% | +10.8% | |
| Net Margin | -24.2% | -14.9% | -17.4% | -22.3% | -4.0% | -20.7% | -32.3% | -50.1% | -77.6% | -41.5% | -38.9% | -43.6% | -65.1% | -76.0% | -34.5% | -25.7% | -31.0% | -48.7% | -90.1% | -15.4% | -40.2% |
| — | +28.2% | +46.2% | +55.3% | +94.8% | +50.0% | +16.9% | -14.8% | -19.2% | +45.5% | -12.9% | -69.8% | -110.3% | -56.2% | +61.7% | -66.4% | +23.0% | +3.7% | -441.6% | +32.6% | -92.0% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -133.3% | -57.6% | -64.6% | -69.8% | -13.1% | -57.0% | -54.1% | -45.2% | -80.5% | -42.9% | -33.7% | -43.0% | -84.0% | -68.6% | -86.1% | — | — | -214.1% | -116.5% | -12.0% | -25.3% |
| — | -1.1% | -19.3% | -54.5% | +83.7% | -32.7% | -60.6% | -5.0% | +4.2% | +37.4% | +60.9% | — | — | +68.0% | +26.1% | — | — | -850.8% | -1447.4% | -27.8% | -246.9% | |
| ROA | -14.5% | -3.0% | -3.3% | -3.8% | -0.8% | -3.3% | -5.0% | -6.1% | -11.0% | -5.9% | -5.9% | -5.7% | -7.6% | -10.5% | -6.8% | -5.7% | -6.8% | -9.6% | -21.7% | -4.2% | -9.9% |
| — | +9.6% | +33.2% | +37.9% | +93.2% | +43.3% | +14.5% | -7.2% | -44.0% | +44.2% | +13.5% | +0.0% | -12.0% | -9.7% | +68.9% | -34.6% | +31.0% | +1.7% | -521.7% | +6.2% | -171.7% | |
| ROIC | -14.6% | -0.9% | -1.5% | -2.3% | -1.4% | -1.5% | -5.4% | -6.6% | -7.4% | -5.2% | -3.8% | -3.8% | -9.8% | -9.9% | -7.5% | -5.3% | -10.2% | -9.8% | -12.0% | -7.6% | -13.7% |
| — | +37.5% | +71.8% | +65.2% | +80.9% | +71.3% | -40.9% | -75.6% | +25.0% | +47.8% | +49.2% | +29.4% | +4.0% | -0.9% | +37.6% | +30.0% | +25.6% | +30.4% | -60.5% | -120.3% | -3.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 11.23 | 17.28 | 12.20 | 17.86 | 11.23 | 15.96 | 10.15 | 5.85 | 4.24 | 6.09 | 4.39 | 3.45 | 10.45 | 6.20 | 3.39 | — | — | 100.11 | 9.30 | 1.14 | 1.07 |
| — | +8.3% | +20.2% | +205.0% | +164.7% | +161.9% | +131.4% | +69.8% | -59.4% | -1.7% | +29.5% | — | — | -93.8% | -63.6% | — | — | +11367.2% | +1100.1% | +56.4% | +52.4% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.04 | 3.57 | 3.84 | 2.96 | 3.04 | 3.33 | 2.84 | 3.36 | 3.56 | 3.62 | 4.44 | 4.24 | 3.06 | 3.71 | 4.83 | 3.43 | 3.85 | 4.27 | 4.50 | 3.01 | 3.55 |
| — | +7.3% | +35.2% | -11.9% | -14.5% | -8.1% | -36.1% | -20.9% | +16.3% | -2.4% | -8.0% | +23.9% | -20.5% | -13.0% | +7.3% | +13.7% | +8.3% | +4.2% | -4.2% | -41.7% | -30.5% | |
| Quick Ratio | 2.00 | 2.38 | 2.52 | 1.91 | 2.00 | 2.10 | 1.67 | 2.05 | 2.41 | 2.29 | 2.91 | 2.73 | 1.67 | 2.36 | 3.53 | 2.31 | 2.91 | 3.29 | 3.74 | 2.23 | 2.66 |
| — | +13.3% | +51.4% | -6.7% | -16.8% | -8.3% | -42.8% | -25.1% | +44.1% | -2.9% | -17.5% | +18.2% | -42.6% | -28.3% | -5.6% | +3.6% | +9.3% | +2.3% | -2.2% | -47.7% | -36.8% | |
| Interest Coverage | -1.30 | -0.48 | -0.67 | -0.85 | -0.64 | -0.73 | -1.62 | -2.38 | -5.04 | -2.04 | -2.23 | -2.60 | -4.31 | -6.77 | -3.37 | -1.96 | -4.79 | -3.64 | -9.79 | -1.41 | -4.76 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 37 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ESTA stock.
Establishment Labs Holdings Inc.'s current P/E is -53.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Establishment Labs Holdings Inc.'s current operating margin is -18.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Establishment Labs Holdings Inc.'s business trajectory between earnings reports.